RxDoctor Payments Data

Richard Smiley, MD

Anesthesiology · New York, NYNPI 1881749612

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $220 of the $320 with a category attached, or 68.7%. 4 manufacturers reported payments, led by Werfen USA LLC at 37.9% of the total.

$320in general payments, 2019–2025

Across 7 payments — averaging $45.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Werfen USA LLC$121
  • Comsort, Inc$100
  • Merck$84
  • Vyaire Medical, Inc.$15
$136,629in research payments, 2019–2025

Across 9 payments — averaging $15,181 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pacira Pharmaceuticals Incorporated$137K

What the payments were for

  • Consulting fees$10031%
  • Food & beverage$22069%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Werfen USA LLC1$121
Comsort, Inc1$100
Merck4$84
Vyaire Medical, Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$320 in reported general payments places this provider in the 75th percentile of 4,157 anesthesiology providers in New York.

See all anesthesiology providers in New York

Medicare billing

Part B allowed, 2024
$11,404
Medicare patients
24
Services billed
48

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anesthesiology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →